Projects
This section presents pharmaceutical projects that are announced from time-to-time around the world.
AstraZeneca to Invest US$4.5 Billion to Expand Manufacturing Facility in Virginia
AstraZeneca has announced plans to invest US$45 billion to expand its manufacturing facility at Rivanna Futures in Albemarle County, Virginia
Amgen to Invest US$650 Million to Expand Manufacturing Operations in the United States
Amgen has announced plans to invest US$650 million to expand its manufacturing operations in the United States
Axplora Expands Farmabios with US$38 Million (€35 Million) Site Development in Italy
Axplora is allocating US$38 million 35 million to expand its Farmabios site in Italy, doubling the footprint of the facility
AbbVie Invests US$195 Million to Expand API Manufacturing in USA
AbbVie plans to invest US$195 million to expand active pharmaceutical ingredient API manufacturing at its North Chicago facility in the United States
AstraZeneca Invests US$50 Billion to Expand Drug Manufacturing and R&D in USA
AstraZeneca plans to invest US$50 billion to expand its drug manufacturing and research and development operations across the United States
Veranova Invests US$50 Million to Expand ADC Manufacturing Facility in Massachusetts, USA
Veranova plans to invest over US$50 million to expand its manufacturing facility in Devens, Massachusetts, USA
Piramal Pharma Invests US$90 Million to Expand Manufacturing Facilities in Kentucky and Michigan, USA
Piramal Pharma plans to invest US$90 million to expand two pharmaceutical manufacturing facilities located in Lexington, Kentucky and Riverview, Michigan, USA
Roche and Genentech Invest US$700 Million for State-of-the-Art Manufacturing Facility in North Carolina, USA
Roche and Genentech plan to invest US$700 million in the development of a cuttingedge drug manufacturing facility in Holly Springs, North Carolina, USA
LGM Pharma Invests US$6 million to Expand Drug Manufacturing Facility in USA
LGM Pharma plans to invest $6 million in expanding its manufacturing facility in Rosenberg, Texas
Delpharm Invests US$148 Million (CAD 200 Million) for State-of-the-Art Sterile Injectable Manufacturing Facility in Canada
Delpharm plans to invest US$148 million CAD 200 million to develop a stateoftheart sterile injectable manufacturing facility in Boucherville, Canada
